Clinical Study

Testing The Effect Of Adding Abiraterone Acetate And Enzalutamide To Metastatic Hormone Refractory Prostate Cancer, When Compared To Enzalutamide Alone

Posted Date: Aug 17, 2017

  • Investigator: Nilesh Patil
  • Co-Investigator: Nilesh Patil
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

The purpose of this study is to compare the effects, good and/or bad, of abiraterone, prednisone and enzalutamide with enzalutamide alone on patients and their cancer to find out which is better. Doctors are uncertain about which way is the best way to tr


To Be Eligible To Participate, Patients Must Have Prostate Cancer That Has Spread And Has Not Responded To Hormonal Therapy.


Abiraterone, Metastatic Prostate Cancer, Enzalutamide, Cancer, A031201

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.